关键字: 类型:
下载页码(大于等于0,小于445):
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 
 生物仿制药产品开发 1451条(本栏目收费,不能显示细节,电话13136136841)
pharmacovigilance,403,407 403 407 
product-specific guidance,403–404 403 404 
regulatory requirements,226–229 226 229 
similar biological products,398–400 398 400 
summary,409–410 409 410 
traceability,407 407 
Evaluate Pharma,421 421 
evaluation immunogenicity,343–344,352–353 343 344 352 353 
evidence totality of background,84 84 
clinical development biosimilar drugs,198–200 198 200 
evidence totality of (cont.)extrapolation,212 212 
extrapolation of indications,275 275 
stepwise approach,2–3 2 3 
exaggerated pharmacology,185 185 
exclusivity competition,418–420 418 420 
external comparability,24 24 
extinction coefficient,65–66 65 66 
extrapolation clinical trial designs,212 212 
in vitro/ex vivo to in vivo activities,134 134 
extrapolation of indications biologics complexity,265 265 
biotechnology-derived proteins,402–403 402 403 
clinical considerations,268–275 268 275 
immunogenicity,272–273 272 273 
introduction,264–265 264 265 
pharmacokinetic/pharmacodynamic studies,269–271 269 271 
quality considerations,265–268 265 268 
quality similarity,265–267 265 267 
risk,267 267 
safety,272–273 272 273 
statistical considerations,275–279 275 279 
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3